Duodenal Ulcer Eradication Therapy

Testing for H. pylori

• All patients with duodenal ulcers should undergo H. pylori testing before initiating eradication therapy, with available non-invasive tests including urea breath test (UBT) and stool antigen testing, which have sensitivities and specificities of 88-95% and 94-92%, respectively 1, 2, 3
• The World Journal of Emergency Surgery recommends that all patients with duodenal ulcers undergo H. pylori testing before initiating eradication therapy 1, 2

First-Line Eradication Regimens

• The standard triple therapy regimen, which includes a proton pump inhibitor (PPI), clarithromycin, and amoxicillin, is recommended as first-line therapy in areas with low clarithromycin resistance, with a duration of 14 days for optimal eradication rates 1, 2, 3
• The American Gastroenterological Association recommends standard triple therapy as first-line therapy for duodenal ulcer eradication in areas with low clarithromycin resistance 1, 2

Second-Line Therapy

• For patients who fail first-line therapy, a second-line regimen including a PPI, levofloxacin, and amoxicillin is recommended, with a duration of 10 days 1, 2, 3
• The European Helicobacter Study Group recommends a second-line regimen including a PPI, levofloxacin, and amoxicillin for patients who fail first-line therapy 1, 2, 3

Timing of Eradication Therapy

• For bleeding peptic ulcers, standard triple therapy should be started after 72-96 hours of intravenous PPI administration, while for non-bleeding ulcers, therapy can be initiated immediately after diagnosis 1, 3, 4
• The International Consensus Conference on Helicobacter pylori recommends that standard triple therapy be started after 72-96 hours of intravenous PPI administration for bleeding peptic ulcers 1, 3

Confirmation of Eradication

• Confirmation of H. pylori eradication is strongly recommended in complicated peptic ulcer disease, gastric ulcer, and cases with poor compliance, with testing performed no earlier than 4 weeks after completing therapy 5
• The National Institute for Health and Care Excellence recommends confirmation of H. pylori eradication in complicated peptic ulcer disease and gastric ulcer 5

Clinical Outcomes

• H. pylori eradication significantly reduces duodenal ulcer recurrence rates, with successful eradication leading to ulcer healing in approximately 90% of cases 1, 2
• The American College of Gastroenterology recommends H. pylori eradication as the primary treatment for duodenal ulcer disease, as it significantly reduces ulcer recurrence rates 1, 2